pre-ipo
Stage
About
Intellia Therapeutics, Inc. is a genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology to treat genetic diseases.
Explore Intellia Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.